Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-03-06 @ 9:47 AM
Study NCT ID:
NCT00377104
Status:
TERMINATED
Last Update Posted:
2013-07-02
First Post:
2006-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | B-cell Chronic Lymphocytic Leukemia | View |
| None | Contiguous Stage II Small Lymphocytic Lymphoma | View |
| None | Noncontiguous Stage II Small Lymphocytic Lymphoma | View |
| None | Stage I Chronic Lymphocytic Leukemia | View |
| None | Stage I Small Lymphocytic Lymphoma | View |
| None | Stage II Chronic Lymphocytic Leukemia | View |
| None | Stage III Chronic Lymphocytic Leukemia | View |
| None | Stage III Small Lymphocytic Lymphoma | View |
| None | Stage IV Chronic Lymphocytic Leukemia | View |
| None | Stage IV Small Lymphocytic Lymphoma | View |
Keywords: